CAR, chimeric antigen receptor; CDC, Centers for Disease Control and Prevention; LEGA-C, Local Elimination Programs Leading to Global Action in HCV; R&D, research and development.
References:
1. Gilead Life Sciences. https://www.gilead.com/purpose/medication-access/global-access/viral-hepatitis. Accessed April 1, 2020.
2. Gilead Life Sciences. https://www.gilead.com/purpose/advancing-global-health/hcvelimination. Accessed April 1, 2020.
3. US Department of Health and Human Services. http://aidsinfo.nih.gov/contentfiles/Ivguidelines/AdultandAdolescentGL.pdf. Updated December 18, 2019. Accessed January 24, 2020.
4. Data on file. Gilead Sciences, Inc.; 2018.
5. Gilead Life Sciences. https://www.gilead.com/science-and-medicine/medicines. Accessed April 1, 2020.
6. Data on file. Gilead Sciences, Inc.; 2020.
7. Data on file. Gilead Sciences, Inc.; 2019.